Clinical Trials Directory

Trials / Unknown

UnknownNCT05673954

Glaucoma Assessment Via Reading Ability

Glaucoma Assessment Via Reading Ability Using Logarithmic Chinese Reading Acuity Chart

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Peking University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To explore a quantitative glaucoma evaluation tool of glaucoma through the dynamic evaluation of reading ability based on logarithmic Chinese reading acuity chart (C-READ), and investigate its feasibility.

Detailed description

Glaucoma is the most common cause of irreversible blindness in the world, and it's marked by the gradual loss of retinal ganglion cells and their optic nerve fibres. Early detection and treatment can successfully prevent the disease's development and prevent blindness. Glaucoma sufferers' near visual qualities, particularly their ability to read, might be compromised. Patients can, however, regain some comfortable reading capacity following glaucoma therapy. The logarithmic Chinese reading acuity chart (C-READ) can be beneficial as a tool for functional vision evaluation, and there is rising clinical interest in this well-standardized, calibrated reading chart. Reading chart standards that allow for equal assessment of reading factors such as acuity and speed are currently lacking. The C-READ approach as a judge of glaucoma patients' status lacks theoretical support, and functional visual evaluation tools are still in their infancy. Therefore, we want to complete these tasks: 1) develop a dynamic analytic system and improve the evaluation criteria for the C-READ testing procedure; 2) confirm the usefulness of C-READ for early glaucoma screening through clinical studies. C-READ will provide a reliable and cost-effective screening technique that is convenient, affordable, and noninvasive.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTC-Read testC-Read is a reliable and valid clinical tool for quantitatively testing the reading ability of readers of simplified Chinese characters.

Timeline

Start date
2023-01-01
Primary completion
2023-12-31
Completion
2024-02-29
First posted
2023-01-06
Last updated
2023-01-06

Source: ClinicalTrials.gov record NCT05673954. Inclusion in this directory is not an endorsement.